In last trading session, Precigen Inc (NASDAQ:PGEN) saw 1.44 million shares changing hands with its beta currently measuring 1.78. Company’s recent per share price level of $1.43 trading at $0.01 or 0.70% at ring of the bell on the day assigns it a market valuation of $422.11M. That closing price of PGEN’s stock is at a discount of -51.75% from its 52-week high price of $2.17 and is indicating a premium of 54.55% from its 52-week low price of $0.65. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.62 million shares which gives us an average trading volume of 1.58 million if we extend that period to 3-months.
For Precigen Inc (PGEN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Precigen Inc (NASDAQ:PGEN) trade information
Upright in the green during last session for gaining 0.70%, in the last five days PGEN remained trading in the red while hitting it’s week-highest on Tuesday, 06/24/25 when the stock touched $1.43 price level, adding 7.74% to its value on the day. Precigen Inc’s shares saw a change of -11.18% in year-to-date performance and have moved -4.03% in past 5-day. Precigen Inc (NASDAQ:PGEN) showed a performance of 1.42% in past 30-days. Number of shares sold short was 27.28 million shares which calculate 15.46 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 6 to the stock, which implies a rise of 76.17% to its current value. Analysts have been projecting 6 as a low price target for the stock while placing it at a high target of 6. It follows that stock’s current price would drop -319.58% in reaching the projected high whereas dropping to the targeted low would mean a loss of -319.58% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 25.76% during past 5 years.
Precigen Inc (NASDAQ:PGEN)’s Major holders
Insiders are in possession of 10.52% of company’s total shares while institution are holding 67.05 percent of that, with stock having share float percentage of 74.93%. Investors also watch the number of corporate investors in a company very closely, which is 67.05% institutions for Precigen Inc that are currently holding shares of the company. PATIENT CAPITAL MANAGEMENT, LLC is the top institutional holder at PGEN for having 18.17 million shares of worth $28.72 million. And as of 2024-06-30, it was holding 7.2017 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 10.25 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.0604 of outstanding shares, having a total worth of $16.19 million.
